Delivery Order SPE2DB20D1100-SPE2DB25FC0H5

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a ceiling value of $22,988.50 and a period of performance through April 11, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed price of $5,301.99 and a period of performance through April 11, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a ceiling value of $2,629.79 and a period of performance ending on May 1, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The delivery order has a ceiling value of $1,052 and a completion date of September 24, 2024. This award is a firm fixed-price contract and is not set aside for any special category of business. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,127.88 and a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (Tirzepatide) 10 mg/0.5 mL pens. The contract has a firm fixed price, a ceiling value of $1,905.41, and a period of performance through April 2025. AmerisourceBergen, a for-profit organization headquartered in Conshohocken, Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a ceiling value of $20,165.02 and a period of performance through October 26, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens, with a ceiling value of $11,093.27 and a period of performance through April 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,194.72, is for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.08, is for the delivery of the prescription medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC0H5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens, a diabetes medication. The contract is a firm fixed price delivery order with a ceiling value of $1,843.66 and a period of performance through May 1, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents open competition. The contract supports the federal government's procurement of pharmaceuticals and medical supplies, particularly for military and veteran healthcare systems.

Generated 7/30/25, 10:15 AM